CLSA Events

CEO & CFO Roundtable Managing the Board

The Board of Directors should be one of the strongest assets a company possesses. It is the one asset that can be both long term and strategic as well as short term and operational. The Board of Directors can function to provide leadership, to be an advisor, to be a sounding board and to even help with implementation in certain circumstances. Within this scope of potential involvement, the board members need to be strategically managed like any other asset. This hard task falls on the CEO, who is charged with maintaining a vibrant and productive board, strategic recruitment, resolving conflicts of interest, aligning visions of the board and executive team, executing effective communications, evaluating board member performance to ensure each director is providing necessary value to the company, and dealing with disruptive or inadequate board members. Attending life sciences CEOs and CFOs will be able to gather and share unique personal insights and recommendations of how to work most effectively with a Board of Directors in both public and private company settings.


Laura Berezin
Partner, Cooley Godward Kronish LLP

Anchoring Companies

Lee Douglas
Director, Affymax, Inc.
Co-founder of COR Therapeutics, Inc

Christine Meda, BSc
President & CEO, Arcxis Biotechnologies

Steve Engle
President/CEO, XOMA, LLC

Thomas J. Schall, Ph.D.
President and CEO, ChemoCentryx, Inc.

David Martin, MD
Chief Executive Officer, AvidBiotics

What: CEO & CFO Roundtable
Managing the Board
When: May 12, 2010
Where: OncoMed Pharmaceuticals, Inc.
800 Chesapeake Dr.,
Redwood City, CA 94063-4748
Parking: Free of charge
Attire: Business attire suggested
Attendance: Open to C Suite Executives of Life Sciences Companies Only.

RSVP by May 1, 2010 is required.
No registrations will be accepted on site.

Cost: BayBio Members – FREE
Non-Members – $75.00